Glycosides from stevia rebaudiana Bertoni possess insulin-mimetic and antioxidant activities in rat cardiac fibroblasts

Oxidative Medicine and Cellular Longevity

Volumn 2017, Issue , 2017, Pages

  Prata, Cecilia ^a   Zambonin, Laura ^a   Rizzo, Benedetta ^a   Maraldi, Tullia ^b   Angeloni, Cristina ^c   Dalla Sega, Francesco Vieceli ^d   Fiorentini, Diana ^a   Hrelia, Silvana ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c UNIVERSITY OF CAMERINO   (Italy)

^d UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANTS; CELL CULTURE; CELL MEMBRANES; ENZYMES; FIBROBLASTS; INSULIN; OXYGEN; PLANTS (BOTANY); RATS; SUGAR SUBSTITUTES; SUGARS;

ANTI-OXIDANT ACTIVITIES; ANTIOXIDANT PROPERTIES; CARDIAC FIBROBLASTS; HEALTH MAINTENANCES; INTRACELLULAR LEVELS; REDUCED GLUTATHIONE; STEVIA REBAUDIANA BERTONI; SUPER OXIDE DISMUTASE;

GLYCOSIDES;

ANTIOXIDANT; CATALASE; GLUCOSE TRANSPORTER 4; GLUTATHIONE; HYPERGLYCEMIC AGENT; INSULIN; LACTATE DEHYDROGENASE; PHOSPHATIDYLINOSITOL 3 KINASE; PLANT GLYCOSIDE; PROTEIN KINASE B; REBAUDIOSIDE A; STEVIOL; STEVIOSIDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; GLYCOSIDE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GLUCOSE TRANSPORT; HEART FIBROBLAST; IN VITRO STUDY; INTRACELLULAR SIGNALING; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PI3K/AKT SIGNALING; PLANT LEAF; POLYMERASE CHAIN REACTION; RAT; STEVIA REBAUDIANA; STRUCTURE ANALYSIS; UPREGULATION; CARDIAC MUSCLE CELL; CHEMICAL STRUCTURE; CHEMISTRY; FIBROBLAST; HUMAN; METABOLISM; STEVIA;

ANTIOXIDANTS; SWEETENERS (PULP);

ANTIOXIDANTS; FIBROBLASTS; GLYCOSIDES; HUMANS; MOLECULAR STRUCTURE; MYOCYTES, CARDIAC; STEVIA;

EID: 85029604474     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2017/3724545     Document Type: Article

References (54)

1. R. Lemus-Mondaca, A. Vega-Galvez, L. Zura-Bravo, and K. Ah-Hen, "Stevia rebaudiana Bertoni, source of a high potency natural sweetener: a comprehensive review on the biochemical, nutritional and functional aspects", Food Chemistry, vol. 132, no. 3, pp. 1121-1132, 2012.
2. S. Purkayastha, A. Markosyan, I. Prakash et al., "Steviol glycosides in purified stevia leaf extract sharing the same metabolic fate", Regulatory Toxicology and Pharmacology, vol. 77, pp. 125-133, 2016.
3. U. Wolwer-Rieck, "The leaves of Stevia rebaudiana (Bertoni), their constituents and the analyses thereof: a review", Journal of Agricultural and Food Chemistry, vol. 60, no. 4, pp. 886-895, 2012.
4. D. D. Soejarto, A. D. Kinghorn, and N. R. Farnsworth, "Potential sweetening agents of plant origin. III. Organoleptic evaluation of Stevia leaf herbarium samples for sweetness", Journal of Natural Products, vol. 45, no. 5, pp. 590-599, 1982.
5. G. Brahmachari, L. C. Mandal, R. Roy, S. Mondal, and A. K. Brahmachari, "Stevioside and related compounds - molecules of pharmaceutical promise: a critical overview", Archiv der Pharmazie (Weinheim, Germany), vol. 344, no. 1, pp. 5-19, 2011.
6. J. M. Geuns, "Stevioside", Phytochemistry, vol. 64, no. 5, pp. 913-921, 2003.
7. G. F. Ferrazzano, T. Cantile, B. Alcidi et al., "Is Stevia rebaudiana Bertoni a non cariogenic sweetener? A review", Molecules, vol. 21, no. 1, article E38, 2015.
8. A. D. Kinghorn, N. Kaneda, N. I. Baek, E. J. Kennelly, and D. D. Soejarto, "Noncariogenic intense natural sweeteners", Medicinal Research Reviews, vol. 18, no. 5, pp. 347-360, 1998.
9. J. C. Ruiz-Ruiz, Y. B. Moguel-Ordonez, and M. R. Segura-Campos, "Biological activity of Stevia rebaudiana Bertoni and their relationship to health", Critical Reviews in Food Science and Nutrition, vol. 57, 2015.
10. V. Chatsudthipong and C. Muanprasat, "Stevioside and related compounds: therapeutic benefits beyond sweetness", Pharmacology & Therapeutics, vol. 121, no. 1, pp. 41-54, 2009.
11. S. K. Goyal, R Samsher, and K. Goyal, "Stevia (Stevia rebaudiana) a bio-sweetener: a review", International Journal of Food Sciences and Nutrition, vol. 61, no. 1, pp. 1-10, 2010.
12. C. Boonkaewwan, C. Toskulkao, and M. Vongsakul, "Antiinflammatory and immunomodulatory activities of stevioside and its metabolite steviol on THP-1 cells", Journal of Agricultural and Food Chemistry, vol. 54, no. 3, pp. 785-789, 2006.
13. C. European Food Safety Authority, "Revised exposure assessment for steviol glycosides for the proposed uses as a food additive", EFSA Journal, vol. 9, no. 1, p. 1972, 2011.
14. J. D. Urban, M. C. Carakostas, and S. L. Taylor, "Steviol glycoside safety: are highly purified steviol glycoside sweeteners food allergens?", Food and Chemical Toxicology, vol. 75, pp. 71-78, 2015.
15. WHO, "WHO expert committee on diabetes mellitus", World Health Organization Technical Report Series, vol. 916, p. 160, 2003.
16. N. H. Mohd-Radzman, W. I. W. Ismail, Z. Adam, S. S. Jaapar, and A. Adam, "Potential roles of Stevia rebaudiana Bertoni in abrogating insulin resistance and diabetes: a review", Evidencebased Complementary and Alternative Medicine, vol. 2013, Article ID 718049, 10 pages, 2013.
17. P. B. Jeppesen, S. Gregersen, C. R. Poulsen, and K. Hermansen, "Stevioside acts directly on pancreatic beta cells to secrete insulin: actions independent of cyclic adenosine monophosphate and adenosine triphosphate-sensitive K-channel activity, Metabolism, vol. 49, no. 2, pp. 208-214, 2000.
18. R Abudula, V. V. Matchkov, P. B. Jeppesen, H. Nilsson, C. Aalkjaer, and K. Hermansen, "Rebaudioside A directly stimulates insulin secretion from pancreatic beta cells: a glucose-dependent action via inhibition of ATP-sensitive K-channels", Diabetes, Obesity & Metabolism, vol. 10, no. 11, pp. 1074-1085, 2008.
19. J. C. Chang, M. C. Wu, I. M. Liu, and J. T. Cheng, "Increase of insulin sensitivity by stevioside in fructose-rich chow-fed rats", Hormone and Metabolic Research, vol. 37, no. 10, pp. 610-616, 2005.
20. P. B. Jeppesen, S. Gregersen, K. K. Alstrup, and K. Hermansen, "Stevioside induces antihyperglycaemic, insulinotropic and glucagonostatic effects in vivo: studies in the diabetic Goto-Kakizaki (GK) rats", Phytomedicine, vol. 9, no. 1, pp. 9-14, 2002.
21. S. Gregersen, P. B. Jeppesen, J. J. Holst, and K. Hermansen, "Antihyperglycemic effects of stevioside in type 2 diabetic subjects", Metabolism, vol. 53, no. 1, pp. 73-76, 2004.
22. M. Ritu and J. Nandini, "Nutritional composition of Stevia rebaudiana-a sweet herb and its hypoglycaemic and hypolipidaemic effect on patients with non insulin dependent diabetes mellitus", Journal of the Science of Food and Agriculture, vol. 96, 2016.
23. S. Bhasker, H. Madhav, and M. Chinnamma, "Molecular evidence of insulinomimetic property exhibited by steviol and stevioside in diabetes induced L6 and 3T3L1 cells", Phytomedicine, vol. 22, no. 11, pp. 1037-1044, 2015.
24. C. Bender, S. Graziano, and B. F. Zimmermann, "Study of Stevia rebaudiana Bertoni antioxidant activities and cellular properties", International Journal of Food Sciences and Nutrition, vol. 66, no. 5, pp. 553-558, 2015.
25. S. Ghanta, A. Banerjee, A. Poddar, and S. Chattopadhyay, "Oxidative DNA damage preventive activity and antioxidant potential of Stevia rebaudiana (Bertoni) Bertoni, a natural sweetener", Journal of Agricultural and Food Chemistry, vol. 55, no. 26, pp. 10962-10967, 2007.
26. N. Shivanna, M. Naika, F. Khanum, and V. K. Kaul, "Antioxidant, anti-diabetic and renal protective properties of Stevia rebaudiana", Journal of Diabetes and its Complications, vol. 27, no. 2, pp. 103-113, 2013.
27. S. Singh, V. Garg, and D. Yadav, "Antihyperglycemic and antioxidative ability of Stevia rebaudiana (Bertoni) leaves in diabetes induced mice", International Journal of Pharmacy and Pharmaceutical Sciences, vol. 5, no. 2, pp. 297-302, 2013.
28. B. Rizzo, L. Zambonin, C. Angeloni et al., "Steviol glycosides modulate glucose transport in different cell types", Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 348169, 11 pages, 2013.
29. D. Zhang, Y. Cui, B. Li, X. Luo, B. Li, and Y. Tang, "miR-155 regulates high glucose-induced cardiac fibrosis via the TGF-beta signaling pathway", Molecular BioSystems, vol. 13, no. 1, pp. 215-224, 2016.
30. G Pandini, F. Frasca, R Mineo, L. Sciacca, R Vigneri, and A. Belfiore, "Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved", The Journal of Biological Chemistry, vol. 277, no. 42, pp. 39684-39695, 2002.
31. K. Reiss, W. Cheng, J. Kajstura, E. H. Sonnenblick, L. G. Meggs, and P. Anversa, "Fibroblast proliferation during myocardial development in rats is regulated by IGF-1 receptors", The American Journal of Physiology, vol. 269, 3, Part 2, pp. H943-H951, 1995.
32. N. Longo, G I. Bell, R C. Shuster, L. D. Griffin, S. D. Langley, and L. J. Elsas, "Human fibroblasts express the insulin-responsive glucose transporter (GLUT4)", Transactions of the Association of American Physicians, vol. 103, pp. 202-213, 1990.
33. S. Hrelia, D. Fiorentini, T. Maraldi et al., "Doxorubicin induces early lipid peroxidation associated with changes in glucose transport in cultured cardiomyocytes", Biochimica et Biophysica Acta, vol. 1567, no. 1-2, pp. 150-156, 2002.
34. L. H. Johansson and L. A. Borg, "A spectrophotometric method for determination of catalase activity in small tissue samples", Analytical Biochemistry, vol. 174, no. 1, pp. 331-336, 1988.
35. T. Maraldi, C. Prata, D. Fiorentini, L. Zambonin, L. Landi, and G. Hakim, "Induction of apoptosis in a human leukemic cell line via reactive oxygen species modulation by antioxidants", Free Radical Biology & Medicine, vol. 46, no. 2, pp. 244-252, 2009.
36. L. Schaffer, C. L. Brand, B. F. Hansen et al., "A novel highaffinity peptide antagonist to the insulin receptor", Biochemical and Biophysical Research Communications, vol. 376, no. 2, pp. 380-383, 2008.
37. Y. Benomar, N. Naour, A. Aubourg et al., "Insulin and leptin induce Glut4 plasma membrane translocation and glucose uptake in a human neuronal cell line by a phosphatidylinositol 3-kinase-dependent mechanism", Endocrinology, vol. 147, no. 5, pp. 2550-2556, 2006.
38. H. X. Chen and E. Sharon, "IGF-1R as an anti-cancer target-trials and tribulations", Chinese Journal of Cancer, vol. 32, no. 5, pp. 242-252, 2013.
39. D. Chanda, J. J. Luiken, and J. F. Glatz, "Signaling pathways involved in cardiac energy metabolism", FEBS Letters, vol. 590, no. 15, pp. 2364-2374, 2016.
40. N. H. Mohd-Radzman, W. I. W. Ismail, S. S. Jaapar, Z. Adam, and A. Adam, "Stevioside from Stevia rebaudiana Bertoni increases insulin sensitivity in 3T3-L1 adipocytes", Evidencebased Complementary and Alternative Medicine, vol. 2013, Article ID 938081, 8 pages, 2013.
41. P. Singh, J. M. Alex, and F. Bast, "Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer", Medical Oncology, vol. 31, no. 1, p. 805, 2014.
42. A. Belfiore, F. Frasca, G Pandini, L. Sciacca, and R Vigneri, "Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease", Endocrine Reviews, vol. 30, no. 6, pp. 586-623, 2009.
43. L. Knudsen, B. F. Hansen, P. Jensen et al., "Agonism and antagonism at the insulin receptor", PLoS One, vol. 7, no. 12, article e51972, 2013.
44. A. Chowdhury, L. Hasselbach, F. Echtermeyer, N. Jyotsana, G Theilmeier, and C. Herzog, "Fibulin-6 regulates pro-fibrotic TGF-beta responses in neonatal mouse ventricular cardiac fibroblasts", Scientific Reports, vol. 7, article 42725, 2017.
45. D. L. Coven, X. Hu, L. Cong et al., "Physiological role of AMP-activated protein kinase in the heart: graded activation during exercise", American Journal of Physiology Endocrinology and Metabolism, vol. 285, no. 3, pp. E629-E636, 2003.
46. J. S. Fisher, "Potential role of the AMP-activated protein kinase in regulation of insulin action", Cell, vol. 2, no. 3, pp. 68-81, 2006.
47. J. W. Baynes and S. R. Thorpe, "Role of oxidative stress in diabetic complications: a new perspective on an old paradigm", Diabetes, vol. 48, no. 1, pp. 1-9, 1999.
48. S. P. Wolff and R T. Dean, "Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes", The Biochemical Journal, vol. 245, no. 1, pp. 243-250, 1987.
49. J. L. Rains and S. K. Jain, "Oxidative stress, insulin signaling, and diabetes", Free Radical Biology & Medicine, vol. 50, no. 5, pp. 567-575, 2011.
50. K. L. Wolfe and R H. Liu, "Cellular antioxidant activity (CAA) assay for assessing antioxidants, foods, and dietary supplements", Journal of Agricultural and Food Chemistry, vol. 55, no. 22, pp. 8896-8907, 2007.
51. C. Angeloni, M. Malaguti, and S. Hrelia, "Antiglycative activity of sulforaphane: a new avenue to counteract neurodegeneration?", Neural Regeneration Research, vol. 10, no. 11, pp. 1750-1751, 2015.
52. L. Vasko, J. Vaskova, A. Fejercakova, G Mojžišová, and J. Porácová, "Comparison of some antioxidant properties of plant extracts from Origanum vulgare, Salvia officinalis, Eleutherococcus senticosus and Stevia rebaudiana", In Vitro Cellular & Developmental Biology - Animal, vol. 50, no. 7, pp. 614-622, 2014.
53. C. N. Hao, Y. J. Geng, F. Li et al., "Insulin-like growth factor-1 receptor activation prevents hydrogen peroxide-induced oxidative stress, mitochondrial dysfunction and apoptosis", Apoptosis, vol. 16, no. 11, pp. 1118-1127, 2011.
54. C. A. Souders, S. L. Bowers, and T. A. Baudino, "Cardiac fibroblast: the renaissance cell", Circulation Research, vol. 105, no. 12, pp. 1164-1176, 2009.